1-15 of 937
The Limits of Traditional AFib Prediction Models in ATTR-CA
Heart MattersThe Limits of Traditional AFib Prediction Models in ATTR-CA
Quality of Life Conversations in ATTR-CM Care
Heart MattersQuality of Life Conversations in ATTR-CM Care
Kevin S. Shah, MD
Supporting Whole-Body Health Through the Gut
NutritionEdgeSupporting Whole-Body Health Through the Gut
Shelina Ramnarine, PhD
Terri DeNeui, DNP, APRN, ACNP-BC
A Multi-Pillar Approach to Cardio-Renal Risk Reduction
Heart MattersA Multi-Pillar Approach to Cardio-Renal Risk Reduction
Brian P. McDonough, MD, FAAFP
Anu Lala, MD
Martha Gulati, MD, MS, FACC, FAHA
Marianna Fontana, MD
Breaking Barriers in Familial Chylomicronemia Syndrome
On the Frontlines of Familial Chylomicronemia SyndromeBreaking Barriers in Familial Chylomicronemia Syndrome
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Robert Hegele MD, FRCPC
- advertisement
Finerenone in HFpEF: Key Insights From ESC HF
CardiologyFinerenone in HFpEF: Key Insights From ESC HF
John W. Ostrominski, MD, MPH
RSV Hospitalization: Cardiorespiratory Risk in Adults
AudioAbstractsRSV Hospitalization: Cardiorespiratory Risk in Adults
Ryan Quigley
Hypertension Across Diverse Populations: Practical Strategies for Equitable Care
Heart MattersHypertension Across Diverse Populations: Practical Strategies for Equitable Care
Alexandria May, PharmD, BCPS
Keith C. Ferdinand, MD, FACC, FAHA , FASPC, FNLA, FPCNA
Treatment Patterns and MRA Use in Patients with HFmrEF/HFpEF: Insights From FRAME-HF and IRIS HF
CardiologyTreatment Patterns and MRA Use in Patients with HFmrEF/HFpEF: Insights From FRAME-HF and IRIS HF
Andrew Patrick Ambrosy, MD, MPH
SPIRIT-HF: Does Spironolactone Improve Outcomes in HFpEF and HFmrEF?
CardiologySPIRIT-HF: Does Spironolactone Improve Outcomes in HFpEF and HFmrEF?
Muthiah Vaduganathan, MD, MPH
Cardiometabolic Considerations in Familial Chylomicronemia Syndrome
On the Frontlines of Familial Chylomicronemia SyndromeCardiometabolic Considerations in Familial Chylomicronemia Syndrome
Steve Jackson, PharmD
Robert H. Eckel, MD, FAHA, FACC, FNLA
- advertisement
Rethinking Risk in Heart Failure with Preserved Ejection Fraction
Heart MattersRethinking Risk in Heart Failure with Preserved Ejection Fraction
Alexandria May, PharmD, BCPS
Javed Butler, MD, MPH, MBA
Connecting Chronic Kidney Disease and Cardiovascular Risk in Primary Care
Heart MattersConnecting Chronic Kidney Disease and Cardiovascular Risk in Primary Care
Alexandria May, PharmD, BCPS
Javed Butler, MD, MPH, MBA
The Cardiovascular Dimension of Psoriatic Arthritis
Living RheumThe Cardiovascular Dimension of Psoriatic Arthritis
